e-therapeutics plc
ETXPF
$0.13
-$0.01-7.14%
OTC PK
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.48% | 2.32% | -3.66% | -27.03% | -4.59% |
| Total Depreciation and Amortization | 1.52% | -26.92% | 3.62% | 21.50% | 4.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.51% | 123.08% | -3.65% | -709.55% | 4.51% |
| Change in Net Operating Assets | 1.47% | 516.94% | -3.64% | -133.37% | 4.58% |
| Cash from Operations | -1.48% | 42.90% | -3.66% | -113.58% | -4.59% |
| Capital Expenditure | -1.46% | -4,596.88% | -3.23% | 69.90% | -5.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.46% | 0.94% | 3.68% | -36.05% | 4.59% |
| Cash from Investing | 0.00% | -99.59% | 3.69% | -34.46% | 4.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 11.43% | 0.00% | 46.29% | 0.00% |
| Issuance of Common Stock | 0.00% | -31.82% | 0.00% | -99.84% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.51% | 10.83% | -3.66% | -101.46% | 4.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.48% | 40.11% | -3.66% | -168.47% | 4.59% |